CorVel Co. (NASDAQ:CRVL – Get Free Report) Director Alan Hoops sold 10,200 shares of CorVel stock in a transaction on Tuesday, February 18th. The shares were sold at an average price of $116.39, for a total transaction of $1,187,178.00. Following the completion of the transaction, the director now owns 118,213 shares in the company, valued at approximately $13,758,811.07. This represents a 7.94 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this link.
CorVel Stock Down 4.4 %
Shares of CRVL traded down $5.20 on Thursday, hitting $114.27. 138,843 shares of the stock traded hands, compared to its average volume of 103,239. The firm has a market capitalization of $5.87 billion, a P/E ratio of 67.22 and a beta of 1.16. The stock’s 50 day moving average is $123.65 and its two-hundred day moving average is $113.48. CorVel Co. has a 1 year low of $76.20 and a 1 year high of $128.61.
CorVel (NASDAQ:CRVL – Get Free Report) last issued its quarterly earnings results on Tuesday, February 4th. The business services provider reported $0.46 EPS for the quarter. CorVel had a net margin of 10.12% and a return on equity of 32.22%.
Hedge Funds Weigh In On CorVel
Analysts Set New Price Targets
Separately, StockNews.com downgraded shares of CorVel from a “buy” rating to a “hold” rating in a report on Tuesday.
Check Out Our Latest Report on CRVL
About CorVel
CorVel Corporation provides workers’ compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions.
Further Reading
- Five stocks we like better than CorVel
- What is the S&P 500 and How It is Distinct from Other Indexes
- Ray Dalio’s Bridgewater Loaded Up on These Stocks in Q4 2024
- What is a Bond Market Holiday? How to Invest and Trade
- Walmart Faces Tariff Headwinds, Consumer Trends Remain Positive
- Stock Market Sectors: What Are They and How Many Are There?
- Tesla: 2 Reasons to Buy, 1 Reason to Run
Receive News & Ratings for CorVel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CorVel and related companies with MarketBeat.com's FREE daily email newsletter.